UPDATE 2-US warns of risk rise with more Tysabri infusions | Reuters
Links shared publicly online about this topic.
- 1,403total visits
UPDATE 2-US warns of risk rise with more Tysabri infusions | Reuters
* Biogen, Elan drug treats multiple sclerosis * 31 cases of serious brain infection confirmed * Biogen shares down slightly, Elan shares flat (Adds Biogen, FDA comments, updates share movement)
View full resource at reuters.com
Tags: Infection, Brain, Encephalitis, Multiple Sclerosis, Drug, FDA, Tysabri
Most Recently Shared on February 5, 2010 at 8:21 pm By:
FDA says Tysabri brain infection risk rises with number of infusions, 31 confirmed cases http://link.reuters.com/meg97h
Advertisement
